Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FRSJ3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,941
Award facts
- Contract value 100% obligated
- $13,941.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,941.39 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count units) under a firm fixed-price contract. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a competitive, non-set-aside procurement from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle that extends through December 2026 and enables the company to furnish a broad range of pharmaceutical products and medical supplies to support military and federal healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly supplies specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's track record demonstrates consistent capability to meet federal procurement requirements through open competition, with delivery orders historically ranging from minimal to substantial values and employing standardized firm fixed-price arrangements. This award reflects AmerisourceBergen's ongoing role as a key pharmaceutical supplier within DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FRSJ3?
SPE2DB25FRSJ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FRSJ3 worth?
The government has obligated $13,941 on SPE2DB25FRSJ3.
Is contract SPE2DB25FRSJ3 an order under another contract?
Yes. SPE2DB25FRSJ3 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRSJ3 competed?
The extent of competition for SPE2DB25FRSJ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award